Results 211 to 220 of about 29,845 (261)

Safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) in homozygous MDR1-mutant collie dogs. [PDF]

Parasit Vectors
Riggs KL, Wang X, Wiseman S.
europepmc   +1 more source

Socio-cultural and structural barriers influencing parents' knowledge and access to information on schistosomiasis in children around Ugandan Lakes. [PDF]

PLoS Negl Trop Dis
Reigl LS, Anyolitho MK, Neema S, Amuyunzu-Nyamongo M, Buhl A, Burrill J, Frese M, Gnahore DA, Hürlimann E, Lavry Épouse Yao LS, Masaku J, Monnier N, Preston A, Sinkeet AS, Steinmann P, Toh A, Okan O, Winkler AS, Lange IL.   +18 more
europepmc   +1 more source

Association between Schistosoma mansoni infection and fecal occult blood in schoolchildren in Mbita, Suba North Sub-County, western Kenya

Biegon JC, Gachohi J, Ngetich BC, Njenga S, Hamano S, Chadeka EA.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Praziquantel

Parasitology Research, 2003
Praziquantel is the drug of choice for the treatment of all forms of schistosomiasis. This review summarizes the main features of the drug, with special attention being given to those aspects that may be of interest to the practicing physician. After a brief mention of the history, the chemistry, the major available brands and their costs, doses and ...
Donato, Cioli, Livia, Pica-Mattoccia
openaire   +2 more sources

Clonorchiasis and Praziquantel

Archives of Internal Medicine, 1985
Human biliary infection with the trematodes Clonorchis sinensis and Opisthorchis viverrini (oriental liver flukes) affects an estimated 20 million people worldwide and is especially prevalent throughout areas of China and southeast Asia. Seven million infections may exist in Thailand alone where 80% of selected populations are infested. 1 United States
Michael A. Kron, Clement C. S. Hsu
openaire   +3 more sources

Schistosomiasis and Praziquantel

Annals of Internal Medicine, 1984
Excerpt To the editor: Last year, in commenting on a review article on praziquantel published in your journal (1), we reported excellent results obtained by treatingSchistosoma haematobiuminfection...
Z. Farid, B. Trabolsi, M. Stek
openaire   +3 more sources

Praziquantel resistance

Expert Opinion on Drug Discovery, 2007
Results from infected patients, not cured by multiple doses of praziquantel (PZQ), have been reported from different geographic locations, suggesting that resistance to the drug may be present. This has been coupled with several in vivo (e.g., studies on mice infected with 'resistant isolates') and in vitro tests (e.g., direct application and ...
Sanaa S, Botros, James L, Bennett
openaire   +2 more sources

Praziquantel and Schistosomiasis

ChemMedChem, 2010
AbstractReview: 70 refs.
Kareem Khoury, Alexander Doemling
openaire   +4 more sources

Schistosomiasis control: praziquantel forever?

Molecular and Biochemical Parasitology, 2014
Since no vaccine exists against schistosomiasis and the molluscs acting as intermediate hosts are not easy to attack, chemotherapy is the main approach for schistosomiasis control. Praziquantel is currently the only available antischistosomal drug and it is distributed mainly through mass administration programs to millions of people every year.
Alessandra Guidi
exaly   +5 more sources